Investigating a hospital superbug's resistance power

Superbug’s resistance power
Acinetobacter microscopic images show a healthy bacterial cell with no colistin treatment, left, then with colistin treatment, and third with a cell disintegrated after exposure to colistin treatment at a higher level. Credit: Flinders University

Treatment of severe infections caused by pathogenic bacteria relies on "last resort" antibiotics, but rising resistance by "superbugs" to most clinically approved drugs leaves patients exposed to possible fatalities.

Flinders University researchers are focusing on how adapt and resist antimicrobial medications—with a new article focusing on hospital strain of Acinetobacter baumannii and its cellular response to important antibiotic colistin.

The World Health Organization names as one of the biggest threats to global health, , and development with a growing number of infections—including pneumonia, tuberculosis, gonorrhea and salmonellosis—becoming harder to treat as antibiotics used to treat them become less effective.

Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality, researchers warn.

"Around the world, there are fewer and fewer new antibiotics being identified and produced for medical use—and this is compounded by the ever-increasing antibiotic resistance seen in causing infections," says Flinders microbial researcher Dr. Sarah Giles.

"If we can understand the bacterial mechanisms, such as this, we can potentially apply new therapies to treat patients—particularly those with multi-drug-resistant bacterial infections."

"We noted that the A. baumannii bacterial strain had a two-part signal system which altered its potential response to antibiotic treatment," says Dr. Sarah Giles, as part of a NHMRC-Flinders University Research Scholarship study.

This "two-component " observed involves a response regulator protein in the StkR/S system acting as a repressor and when genetically removed hundreds of transcriptional changes are seen.

Some of these changes affect the bacterial cell's outer membrane composition leading to colistin resistance.

"Colistin is known as a 'last resort' antibiotic and therefore identifying and understanding the mechanisms contributing to bacterial antibiotic-resistant is critical," says senior researcher Professor Melissa Brown.

Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and even death.

The article, The StkSR Two-Component System Influences Colistin Resistance in Acinetobacter baumannii (May 2022), by Sarah K Giles, Uwe H Stroeher, Bhavya Papudeshi, Rob Edwards, Jessica AP Carlson-Jones, Michael Roach and Melissa H Brown has been published in the Microorganisims.


Explore further

Scientists discover new phage therapy combination to combat antibiotic-resistance

More information: Sarah K. Giles et al, The StkSR Two-Component System Influences Colistin Resistance in Acinetobacter baumannii, Microorganisms (2022). DOI: 10.3390/microorganisms10050985
Citation: Investigating a hospital superbug's resistance power (2022, May 30) retrieved 25 June 2022 from https://phys.org/news/2022-05-hospital-superbug-resistance-power.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
27 shares

Feedback to editors